当前位置: X-MOL 学术Theranostics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19: Progress in diagnostics, therapy and vaccination.
Theranostics ( IF 12.4 ) Pub Date : 2020-6-19 , DOI: 10.7150/thno.47987
Xue Liu 1 , Chao Liu 2 , Gang Liu 2 , Wenxin Luo 1 , Ningshao Xia 1
Affiliation  

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.

中文翻译:

COVID-19:在诊断,治疗和疫苗接种方面取得进展。

由严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)引起的冠状病毒病2019(COVID-19)最近已成为大流行病。由于SARS-CoV-2的突然出现和迅速传播正威胁着全球健康和经济,因此迫切需要制定遏制病毒传播的策略。目前,可以使用各种诊断试剂盒来测试SARS-CoV-2,以更快地启动适当的治疗并限制病毒的进一步传播。几种药物已在体外证明抗SARS-CoV-2活性或潜在的临床益处。此外,全世界的机构和公司都在不懈地努力开发针对COVID-19的疗法和疫苗。但是,尚未针对COVID-19专门批准任何药物或疫苗。考虑到爆发的紧迫性,我们将重点放在针对SARS-CoV-2感染的诊断,治疗和疫苗开发方面的最新进展,以帮助指导应对当前COVID-19大流行的策略。
更新日期:2020-06-23
down
wechat
bug